Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension
Clinical trial NCT02960204 · COMPLETED
Trial details
- NCT number
- NCT02960204
- Sponsor
- Histogen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-17
- Primary completion
- 2018-10-02
- Enrollment
- 263
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.